Subdural Hematoma Due to Probable Warfarin-Fluorouracil Interaction

Journal of Pharmacy Technology

Volumn 20, Issue 2, 2004, Pages 77-79

  Giunta, Giovanni ^a,b   Velluti, Francesca ^a  

^a Unit for the Diagnosis and Therapy of Osteoporosis   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; WARFARIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FATALITY; FEMALE; HEADACHE; HEART ATRIUM FIBRILLATION; HEMIPARESIS; HUMAN; INTERNATIONAL STANDARD UNIT; MASTECTOMY; MONITORING; OCCIPITAL CORTEX; PARIETAL LOBE; SUBDURAL HEMATOMA;

EID: 1642294760     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250402000203     Document Type: Article

References (17)

1. Hirsch J. Oral anticoagulant drugs. N Engl J Med 1991;324:1865-75.
2. Winer EP, Morrow M, Osborne GK, Harris JR. Malignant tumors of the breast. Section 2. Adjuvant chemotherapy. In: Devita VT, Hellman S, Rosemberg SA, eds. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1692-7.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Scarfe MA, Israel MK. Possible drug interaction between warfarin and combination of levamisole and fluorouracil. Ann Pharmacother 1994;28:464-7.
5. Wehbe TW, Warth JA. A case of bleeding requiring hospitalization that was likely caused by an interaction between warfarin and levamisole. Clin Pharmacol Ther 1996;59:360-2.
6. Brown MC. Interaction between warfarin and 5-fluorouracil, not between warfarin and levamisole (letter). Clin Pharmacol Ther 1998;64:233.
7. Wajima T, Mukhopadhyay P. Possible interaction between warfarin and 5-fluorouracil (letter). Am J Hematol 1992;40:238.
8. Kolesar JM, Johnson CL, Freeberg BL, Berlin JD, Schiller JH. Warfarin-5-FU interaction - a consecutive case series. Pharmacotherapy 1999;19:1445-9.
9. Brown MC. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil. Pharmacotherapy 1997;17:631-3.
10. Brown MC. An adverse interaction between warfarin and 5-fluorouracil: a case report and review of the literature. Chemotherapy 1999;45:392-5.
11. Aki Z, Kotiloglu G, Ozyilkan O. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin (letter). Am J Gastroenterol 2000;95:1093-4.
12. Malacarne P, Maestri A. Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities (letter). Recent Prog Med 1996;87:135.
13. Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 2003;21:736-9.
14. Goldstein JA, De Morais SMF. Biochemistry and molecular biology of the human CYP 2C subfamily. Pharmacogenetics 1994;4:285-99.
15. McEvoy GK, ed. AHFS drug information 1993. Bethesda, MD: American Society of Hospital Pharmacists 1993:827.
16. Chu E, Mota AC, Fogarasi MC. Antimetabolites. In: Devita VT, Hellman S, Rosemberg SA, eds. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:394-8.
17. Afsar A, Lee C, Riddik DS. Modulation of the expression on constitutive rat hepatic cytochrome p450 isoenzymes by 5-fluorouracil. Cancer J Physiol Pharmacol 1996;74:150-6.